A
10.03
0.49 (5.14%)
| Previous Close | 9.54 |
| Open | 9.37 |
| Volume | 735,019 |
| Avg. Volume (3M) | 1,981,191 |
| Market Cap | 1,445,814,400 |
| Price / Sales | 2.28 |
| Price / Book | 50.98 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Profit Margin | -26.51% |
| Operating Margin (TTM) | -11.83% |
| Diluted EPS (TTM) | -1.13 |
| Quarterly Revenue Growth (YOY) | 28.10% |
| Total Debt/Equity (MRQ) | 6,465.30% |
| Current Ratio (MRQ) | 2.73 |
| Operating Cash Flow (TTM) | -44.65 M |
| Levered Free Cash Flow (TTM) | -78.58 M |
| Return on Assets (TTM) | -9.72% |
| Return on Equity (TTM) | -291.71% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Alphatec Holdings, Inc. | Bullish | Mixed |
AIStockmoo Score
1.1
| Analyst Consensus | 1.0 |
| Insider Activity | 3.0 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 1.10 |
|
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 25.18% |
| % Held by Institutions | 59.86% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 21.00 (Barclays, 109.37%) | Buy |
| Median | 18.00 (79.46%) | |
| Low | 13.00 (Piper Sandler, 29.61%) | Buy |
| Average | 17.50 (74.48%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 11.34 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 14 Apr 2025 | 20.00 (99.40%) | Buy | 9.75 |
| Needham | 27 Feb 2025 | 16.00 (59.52%) | Buy | 12.12 |
| Piper Sandler | 27 Feb 2025 | 13.00 (29.61%) | Buy | 12.12 |
| Barclays | 22 Jan 2025 | 21.00 (109.37%) | Buy | 11.38 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| HUNSAKER CRAIG E | 10.08 | - | 21,751 | 219,250 |
| KONING JOHN TODD | 10.08 | - | 20,929 | 210,964 |
| LISH SCOTT | 10.08 | - | 21,751 | 219,250 |
| MARSHALL TYSON ELIOT | 10.08 | - | 19,848 | 200,068 |
| MILES PATRICK | 10.08 | - | 16,475 | 166,068 |
| SPONSEL DAVID | 10.08 | - | 3,866 | 38,969 |
| Aggregate Net Quantity | 104,620 | |||
| Aggregate Net Value ($) | 1,054,570 | |||
| Aggregate Avg. Buy ($) | 10.08 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LISH SCOTT | Officer | 01 Apr 2025 | Acquired (+) | 21,751 | 10.08 | 219,250 |
| HUNSAKER CRAIG E | Officer | 01 Apr 2025 | Acquired (+) | 21,751 | 10.08 | 219,250 |
| MARSHALL TYSON ELIOT | Officer | 01 Apr 2025 | Acquired (+) | 19,848 | 10.08 | 200,068 |
| KONING JOHN TODD | Officer | 01 Apr 2025 | Acquired (+) | 20,929 | 10.08 | 210,964 |
| MILES PATRICK | Officer | 01 Apr 2025 | Acquired (+) | 16,475 | 10.08 | 166,068 |
| SPONSEL DAVID | Officer | 01 Apr 2025 | Acquired (+) | 3,866 | 10.08 | 38,969 |
| Date | Type | Details |
|---|---|---|
| 14 Apr 2025 | Announcement | ATEC to Report First Quarter 2025 Financial Results on May 1, 2025 |
| 04 Mar 2025 | Announcement | ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering |
| 03 Mar 2025 | Announcement | ATEC Announces Proposed Convertible Senior Notes Offering |
| 26 Feb 2025 | Announcement | ATEC Reports Fourth Quarter and Full Year 2024 Financial Results |
| 24 Feb 2025 | Announcement | ATEC to Participate in Upcoming Conferences |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |